unmet needs in hemophilia: guidelines for emicizumab & better therapeutics for hemophilia a
Published 2 years ago • 188 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
0:51
unmet need in hemophilia a: breakthrough bleeds
-
1:18
unmet needs in hemophilia treatment
-
4:01
emicizumab for hemophilia a: interim analysis of the real-world emiil study
-
1:09
low-dose emicizumab prophylaxis in patients with severe hemophilia a
-
1:23
the present and future of hemophilia a treatment
-
2:15
emicizumab prophylaxis instead of immunosuppressive therapy in patients with acquired hemophilia a
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
10:25
hemophilia a boy - hemlibra injection
-
6:56
hemlibra® (emicizumab-kxwh) mechanism of action for haemophilia a
-
7:29
video 1 - what is hemophilia?
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:46
unmet needs in hemophilia b: treating patients who develop inhibitors
-
19:56
unmet needs in hemophilia | world federation of hemophilia 2018
-
2:49
insights into areas of unmet need among patients with hemophilia a
-
3:45
how emicizumab has changed hemophilia a management
-
6:11
haven 7: emicizumab prophylaxis for the treatment of infants with severe hemophilia a
-
1:17
the current standard of care in hemophilia and unmet needs in this space
-
2:47
real-world data on the safety of emicizumab in patients with hemophilia a
-
4:18
haven 6: emicizumab prophylaxis in non-severe hemophilia a without fviii inhibitors
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
-
1:27
the impact of emicizumab on the hemophilia treatment landscape
-
1:39
therapeutic potential of ides in hemophilia a with inhibitors